Financials

News Ideas Discussions Technicals Forecast Seasonals Bonds

REGN fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Regeneron Pharmaceuticals, Inc.

Total assets of REGN for Q2 24 is 36.09 B USD, 5.00% more than the previous Q1 24. And total liabilities increased by 6.81% in Q2 24 to 7.88 B USD.

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—